Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)

Historical Holders from Q4 2020 to Q3 2025

Symbol
TVTX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
89,414,894
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
100,723,656
Holdings value
$2,407,289,690
% of all portfolios
0.004%
Number of holders
233
Number of buys
124
Number of sells
-105
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 11.9% -6.9% $253,331,874 -$17,690,876 10,599,660 -6.5% JANUS HENDERSON GROUP PLC 30 Sep 2025
ARMISTICE CAPITAL, LLC 7.52% -24.7% $160,703,600 -$51,337,200 6,724,000 -24.2% Armistice Capital, LLC 30 Sep 2025
BlackRock, Inc. 7.5% -21.1% $122,617,344 -$24,357,949 6,689,435 -16.6% BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 6.74% +18.2% $88,715,388 +$14,507,892 5,994,283 +19.6% The Vanguard Group 30 Jun 2025
PERCEPTIVE ADVISORS LLC 5.5% $117,005,198 4,895,615 Perceptive Advisors LLC 06 Oct 2025
MACQUARIE GROUP LTD 5.41% +10.2% $87,934,766 +$9,857,086 4,797,314 +12.6% Macquarie Group Limited 31 Mar 2025
Rock Springs Capital Management LP 3.3% -40.3% $53,545,523 -$37,621,463 2,921,196 -41.3% Rock Springs Capital Management LP 31 Mar 2025
Woodline Partners LP 2.4% $38,750,646 2,114,056 Woodline Partners LP 31 Dec 2024

Institutional Holders of Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 100,723,656 $2,407,289,690 +$19,761,132 $23.9 233
2025 Q2 100,531,635 $1,487,836,300 +$12,972,115 $14.8 207
2025 Q1 98,007,579 $1,771,747,554 +$87,075,624 $17.92 214
2024 Q4 95,064,656 $1,655,970,325 +$204,069,962 $17.42 194
2024 Q3 82,734,245 $1,157,476,987 -$64,293,173 $13.99 175
2024 Q2 87,955,117 $723,000,948 +$2,540,410 $8.22 168
2024 Q1 87,706,388 $676,170,447 +$11,374,907 $7.71 172
2023 Q4 85,573,515 $769,316,791 +$27,493,568 $8.99 162
2023 Q3 82,430,217 $736,935,857 -$48,196,261 $8.94 166
2023 Q2 82,714,633 $1,270,488,775 -$85,984,898 $15.36 165
2023 Q1 84,151,882 $1,892,538,812 +$263,849,900 $22.49 171
2022 Q4 72,978,794 $1,535,405,782 +$36,464,951 $21.03 153
2022 Q3 69,779,173 $1,719,469,986 -$2,015,044 $24.64 168
2022 Q2 69,489,567 $1,683,983,339 +$17,370,839 $24.23 166
2022 Q1 69,479,485 $1,789,961,946 +$97,223,694 $25.77 166
2021 Q4 65,477,167 $2,032,139,426 +$61,452,684 $31.04 165
2021 Q3 60,858,590 $1,476,104,164 +$4,235,576 $24.25 145
2021 Q2 60,583,594 $883,983,031 -$73,514,650 $14.59 131
2021 Q1 62,621,768 $1,563,390,183 +$254,685,025 $24.97 147
2020 Q4 52,293,956 $1,423,328,983 +$1,416,953,984 $27.26 135